Cart
sales@molnova.com
[D-Phe12]-Bombesin
CAS No. 108437-87-2
[D-Phe12]-Bombesin( ——— )
Catalog No. M42097 CAS No. 108437-87-2
[D-Phe12]-Bombesin is a derivative of Bombesin and an antagonist for bombesin receptor with Ki of 4.7 μM. [D-Phe12]-Bombesin inhibits the Bombesin -induced amylase release, with IC50 of 4 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 423 | Get Quote |
|
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name[D-Phe12]-Bombesin
-
NoteResearch use only, not for human use.
-
Brief Description[D-Phe12]-Bombesin is a derivative of Bombesin and an antagonist for bombesin receptor with Ki of 4.7 μM. [D-Phe12]-Bombesin inhibits the Bombesin -induced amylase release, with IC50 of 4 μM.
-
DescriptionBombesin receptor antagonist
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorBombesin receptor
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number108437-87-2
-
Formula Weight1629.88
-
Molecular FormulaC74H112N22O18S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Heinz-Erian P, et al., D-Phe12bombesin analogues: a new class of bombesin receptor antagonists. Am J Physiol. 1987 Mar;252(3 Pt 1):G439-42. ?
molnova catalog
related products
-
PLGA
PLGA is be used to fabricate devices for drug delivery and tissue engineering applications.
-
BDNF (human)
Member of the neurotrophin growth factor family that binds and activates TrkB and p75 neurotrophin receptors. Enhances the survival, growth and differentiation of neurons. BDNF expression is altered in neurodegenerative disorders such as Parkinson's and Alzheimer's disease.
-
(E)-4-Hydroxytamoxif...
(E)-4-Hydroxytamoxifen ((E)-Afimoxifene), the less active isomer of (Z)-4-hydroxytamoxifen, is an estrogen receptor modulator.
